Skip to main content

Share your thoughts about the Research Communities in our survey.

ETHICAL, LEGAL AND SOCIAL ISSUES IN HUMAN BRAIN ORGANOID RESEARCH - a hypothetical public consultation paper in anticipation of future actions by the Bioethics Advisory Committee (BAC) of Singapore

This is an independent, hypothetical public consultation paper on human brain organoids for discussion and educational purposes only. It has not been issued, approved, or endorsed by the Bioethics Advisory Committee of Singapore, the Ministry of Health, or any other Singapore Government agency.

Alexis Heng Boon Chin

Sep 19, 2026

ETHICAL, LEGAL, AND SOCIAL ISSUES ARISING FROM RESEARCH ON HUMAN STEM CELL-BASED EMBRYO MODELS - a legal grey area requiring future public consultation by the Bioethics Advisory Committee (BAC) of Singapore

Existing laws like Singapore's Human Biomedical Research Act and the Human Cloning Act define embryos based on fertilization. Because SCBEMs do not involve fertilization, they currently sit in a regulatory gap, necessitating a public consultation by Singapore's Bioethics Advisory Committee (BAC).

Alexis Heng Boon Chin

Sep 18, 2026

Singapore’s Fertility Health Support and Increased Financial Assistance for IVF and other Assisted Conception Procedures must Safeguard against Wasteful Medical Spending

Increased public funding of fertility treatments risks freeing spare cash for doubtful medical extras. Singapore must fund evidence-based treatment, not clinic upselling. The Ministry of Health (MOH) should adopt a traffic-light rating for IVF add-ons similar to that developed by HFEA in the UK.

Alexis Heng Boon Chin

Aug 24, 2026

PGT-A Singapore - Should MOH approve PGT-A as a Mainstream Clinical Treatment Procedure?

Singapore must beware of private IVF clinics hard-selling the PGT-A procedure to desperate and vulnerable patients by exploiting their fears of Down syndrome. This leads to unnecessary anxiety, financial exploitation, and loss of potentially viable “mosaic” embryos that can self-correct.

Alexis Heng Boon Chin

Aug 12, 2026

Increasing the CPF MediSave Lifetime Withdrawal Limit for IVF and Other Assisted Conception Procedures in Singapore - A Policy White Paper

Singapore should raise the CPF MediSave lifetime withdrawal limit for IVF and other Assisted Conception Procedures to adjust for inflation. However, stringent and robust safeguards are necessary to prevent private IVF clinics from hard-selling dubious IVF add-on procedures with doubtful efficacy.

Alexis Heng Boon Chin

Aug 06, 2026

Raise Singapore's MediSave Lifetime Withdrawal Limit for IVF with Robust Safeguards

Singapore's CPF MediSave lifetime withdrawal limit for IVF—has remained stubbornly fixed at S$15,000 since 2004. This outdated cap, conceived two decades ago, has been silently eroded by inflation, leaving couples to bear an increasingly heavy financial burden. It is time for a reset to S$25,000.

Alexis Heng Boon Chin

Aug 02, 2026

Female Hypergamy and Assortative Mating in Singapore - Addressing Graduate Women’s Mismatched Marriage Expectations is Crucial for Tackling the Nation’s Fertility and Demographic Crisis

Due to women graduating from universities at significantly higher rates than men in Singapore, this has led to a mating gap or marriage squeeze, as highly educated, high-earning women find themselves competing for a dwindling number of men who meet their hypergamous criteria.

Alexis Heng Boon Chin

Jul 30, 2026

PGT-A in Singapore - Down Syndrome Anxiety and Fear in Singapore Among Older Women Can Be Exploited by the IVF Industry to Hard Sell the Controversial PGT-A Technique - A Policy White Paper

The IVF industry exploits Down syndrome anxiety and fear among older women to market PGT-A. Clinical evidence shows no improvement in IVF success rates and exposes misdiagnosis risks. More transparency and stringent regulations are needed to curtail misleading and unethical marketing practices.

Alexis Heng Boon Chin

Jul 19, 2026

Singapore Government Co-funding of Private IVF Treatment: A Competitive Public Tender Procurement Model

This white paper proposes a competitive public tender procurement model for Singapore government co-funding of private IVF treatment, analogous to the established Government Electronic Business (GeBIZ) framework, under which private IVF clinics would submit price-capped bids for basic IVF cycles.

Alexis Heng Boon Chin

Jul 03, 2026

Singapore should not Invest in Research and Development (R&D) of In Vitro Gametogenesis (IVG) Technology for Human Clinical Assisted Reproduction

Singapore’s highly restrictive laws governing assisted reproduction—specifically the ban on surrogacy, the exclusion of same-sex couples from accessing fertility treatments, and strict limits on the number of donor offspring—will severely stifle any return on investment in IVG technology.

Alexis Heng Boon Chin

May 28, 2026

Policy Actions on In Vitro Fertilization (IVF) and Assisted Reproductive Technologies (ARTs) to Address Singapore's Fertility and Demographic Challenges

As the Singapore government deliberates policy actions on IVF and other ARTs to address the nation's low birthrate, it must carefully consider caveats and potential pitfalls to ensure effective and ethically sound outcomes.

Alexis Heng Boon Chin

May 22, 2026

Reform Singapore's Education System to Counter Fertility and Demographic Decline - A Policy Assessment White Paper

Singapore's competitive educational system is in urgent and dire need of radical reforms to overcome the nation's fertility and demographic crisis.

Alexis Heng Boon Chin

May 20, 2026

News and Opinion

Should Singapore Legislate Paid Fertility Leave for IVF Treatment? A Policy Brief and White Paper.

Legislated fertility leave is the decisive, common-sense step that Singapore must take to secure her demographic future.

Alexis Heng Boon Chin

May 06, 2026

Should Singapore’s CPF MediSave Fund Elective Egg Freezing (EEF) and PGT-A? A Policy Evaluation White Paper

Should Singapore’s CPF MediSave Fund Elective Egg Freezing (EEF) and PGT-A? A Policy Evaluation White Paper

Alexis Heng Boon Chin

May 02, 2026

Singapore Government Co-funding and Subsidies for Private IVF Treatment - A Policy Risk Assessment White Paper

News and Opinion

Singapore Government Co-funding and Subsidies for Private IVF Treatment - A Policy Risk Assessment White Paper

Alexis Heng Boon Chin

Apr 26, 2026

Should Singapore Raise or Lift the Current Age Limit of Elective Egg Freezing to Beyond 37 Years Old?

Should Singapore Raise or Lift the Current Age Limit of Elective Egg Freezing to Beyond 37 Years Old?

Alexis Heng Boon Chin

Apr 23, 2026

Asian Bioethics Review

Behind the Paper

PGT-WGS (Preimplantation Genetic Testing with Whole Genome Sequencing) in Malaysia and Singapore

IVF Patients Beware! Profit-driven fertility clinics can readily exploit patients' ignorance and current sociocultural conditions to market the PGT-WGS platform that combines PGT-A, PGT-M, PGT-SR, and PGT-P for comprehensive IVF genetic testing, even though it cannot improve IVF success rates.

Alexis Heng Boon Chin

Mar 28, 2026

Singapore TFR (Total Fertility Rate) - Consequences of Female Hypergamy, Child Perfectionism, and Misuse of New Reprogenetic Technologies such as Polygenic Embryo Screening (PES) and Gene Editing

News and Opinion

Singapore TFR (Total Fertility Rate) - Consequences of Female Hypergamy, Child Perfectionism, and Misuse of New Reprogenetic Technologies such as Polygenic Embryo Screening (PES) and Gene Editing

Alexis Heng Boon Chin

Feb 14, 2026